Abstract:Background: Erythrocyte alloantibodies and autoantibodies complicate transfusion. However, the prevalence of erythrocyte alloimmunization and autoimmunization has not been estimated in the Chinese pediatric population. Therefore, we investigated the prevalence of erythrocyte alloimmunization and autoimmunization in the Chinese pediatric population with the aim of developing a reasonable transfusion management policy in children from China. Methods: This study included 30,603 pediatric inpatients who were admitted to three tertiary hospitals in central China from May 2020 to October 2022. Antibody screening was carried out with a three-cell panel by column agglutination technology, and samples with positive screening were analyzed for antibody specificity with a 16-cell identification panel. Clinical details of the patients were collected to identify associations with antibody formation. Results: The alloimmunization rate was 0.55% (169/30,603), and the autoimmunization rate was 0.14% (43/30,603). Alloantibodies comprised 80.09% of the antibodies. The most frequent alloantibodies were anti-M (58.77%), anti-E (9.48%), and anti-P1 (4.27%). Autoantibodies comprised 19.91% of antibodies. Age ( p = 0.000), sex ( p = 0.016), geographical area ( p = 0.000), ABO blood group ( p = 0.008), and diagnosis ( p = 0.000) were independent risk factors for antibody formation. The risk of antibody formation at the ages of 0–28 days and 1–3 months was zero (odds ratio = 0.000). The antibody distribution was significantly different by age ( p = 0.000) and diagnosis ( p = 0.000). Conclusion: Repeat pre-transfusion testing for infants less than 4 months of age can be omitted for no risk of antibody formation. MNS system antibodies, especially anti-M, are prominent in younger children, and this decreases with age. Provision of extended phenotype-matched transfusion for Rh system antigens, especially antigen E, is necessary in children to control erythrocyte alloimmunization. The presence of antibodies with high evanescence rates in the pediatric population suggests the pressing need for nationwide shared transfusion records to avoid hemolytic transfusion reactions in children.

Alloimmunization Induced by RhD Antigens During Apheresis Platelet Concentrates Transfusion and Its Clinical Application

Red blood cell alloimmunization in transfused patients with myelodysplastic syndromes: a retrospective study from northern China

Clinical Significance of Screening of Rh-negative Blood Group and Detection of Irregular Antibody

Anti-E alloimmunization from a platelet apheresis transfusion in a 22-month-old male with acute myeloid leukemia

Prolonged Thrombocytopenia and Severe Transfusion Reaction after ABO-Incompatible Allogeneic Hematopoietic Stem Cell Transplantation in a Patient with Chronic Myelomonocytic Leukemia

Analysis of Rhesus (Rh) Antigen Distributions in Donors and Multi-transfused Patients for Phenotype-Matched Transfusion

Timing of RhD-positive red blood cell administration is associated with D-alloimmunization in injured patients

Human RBC Alloimmunization Evaluation after Exposure to Foreign E Antigen of the Rhesus System in Transfusion

Secondary Alloanti-D Immunization Post Transfusion of “asia Type” DEL Red Blood Cells

Prospective Evaluation of A Transfusion Policy of Rhd-Positive Red Blood Cells into Del Patients in China

Transfusion‐induced Platelet Antibodies and Regulatory T Cells in Multiply Transfused Patients

RhD-positive red blood cell allocation practice to RhD-negative patients before and during the COVID-19 pandemic

The Necessity of Clinical Rh Phenotypic Serological Detection and Homotypic Infusion in Patients with Repeated Blood Transfusion

Pre-transfusion Testing Using Crossmatching Agglutination Reaction Grades Combined With Rh Subgroup Phenotyping in Patients With Autoantibodies: A Three-year Experience at a Tertiary Hospital

Incidence of anti-D alloimmunization in D-negative individuals receiving D-positive red blood cell transfusion: A systematic review and meta-analysis

Rh immune globulin immunoprophylaxis after RhD‐positive red cell exposure in RhD‐negative patients via transfusion: A survey of practices

RH genotypes and red cell alloimmunization rates in chronically transfused patients with sickle cell disease: A multisite study in the USA

Platelet concentrate and type II IL-1 receptor are risk factors for allergic transfusion reactions in children

Erythrocyte Alloimmunization and Autoimmunization in the Pediatric Population: A Multicenter, Cross-Sectional Study in Central China

Not as "D"eadly as once thought - the risk of D-alloimmunization and hemolytic disease of the fetus and newborn following RhD-positive transfusion in trauma

RhD‐negative red blood cells can be saved during liver transplantation in RhD‐negative patients due to low risk of alloimmunization against RhD